Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer’s Manufacturing Cost-Cutting May Leave Little Capacity For Growth

Executive Summary

Following its restructuring, Pfizer's in-house manufacturing capacity will support approximately $48 billion in sales

You may also be interested in...



Pfizer Tasks “Established Products Unit” With Extending Life Of Mature Drugs

As Pfizer faces a future without several key blockbuster drugs, Lipitor among them, the company is setting out to extend the life of its mature franchises with the formation of a dedicated business unit for established brands

Pfizer Tasks “Established Products Unit” With Extending Life Of Mature Drugs

As Pfizer faces a future without several key blockbuster drugs, Lipitor among them, the company is setting out to extend the life of its mature franchises with the formation of a dedicated business unit for established brands

Year In Review: Is Big Pharma Getting Smaller? Cost-Cutting Fails To Revive Rx Stocks

As the pharmaceutical industry wades through its second spate of major restructuring initiatives in the last three years, investors may be weighing whether the programs reflect efforts to improve efficiency in the face of short-term setbacks, or suggest a more fundamental long-term downsizing of the brand industry

Related Content

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel